Survivin	O
expression	O
in	O
breast	B-Cancer
carcinoma	I-Cancer
:	O
correlation	O
with	O
apoptosis	O
and	O
prognosis	O
.	O

BACKGROUND	O
:	O
Survivin	O
is	O
a	O
novel	O
inhibitor	O
of	O
apoptosis	O
commonly	O
detected	O
in	O
tissues	B-Tissue
during	O
fetal	B-Developing_anatomical_structure
development	O
and	O
in	O
cancer	B-Cancer
,	O
but	O
not	O
usually	O
in	O
normal	O
tissues	B-Tissue
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
expression	O
of	O
this	O
protein	O
may	O
be	O
of	O
prognostic	O
significance	O
in	O
gastric	B-Cancer
,	O
colorectal	B-Cancer
,	O
and	O
bladder	B-Cancer
carcinomas	I-Cancer
.	O

We	O
assessed	O
survivin	O
expression	O
in	O
breast	B-Cancer
carcinomas	I-Cancer
correlating	O
results	O
with	O
expression	O
of	O
other	O
antiapoptotic	O
(	O
bcl	O
-	O
2	O
,	O
bcl	O
-	O
x	O
)	O
and	O
proapoptotic	O
(	O
bax	O
)	O
markers	O
,	O
with	O
prognostic	O
parameters	O
,	O
and	O
with	O
prognosis	O
.	O

DESIGN	O
:	O
Paraffin	O
-	O
embedded	O
sections	B-Cancer
of	O
37	O
breast	B-Cancer
carcinomas	I-Cancer
were	O
immunostained	O
for	O
survivin	O
,	O
bcl	O
-	O
2	O
,	O
bcl	O
-	O
x	O
,	O
and	O
bax	O
.	O

Expression	O
was	O
evaluated	O
in	O
normal	O
breast	B-Tissue
tissue	I-Tissue
and	O
carcinoma	B-Cancer
,	O
nuclei	B-Cellular_component
and	O
cytoplasm	B-Organism_substance
,	O
as	O
intensity	O
(	O
0	O
to	O
3	O
+	O
)	O
,	O
and	O
percentage	O
of	O
positive	O
cells	B-Cell
.	O

RESULTS	O
:	O
Survivin	O
expression	O
was	O
noted	O
in	O
30	O
(	O
81	O
%	O
)	O
of	O
breast	B-Cancer
carcinomas	I-Cancer
,	O
and	O
in	O
normal	O
breast	B-Tissue
tissue	I-Tissue
,	O
in	O
nuclei	B-Cellular_component
,	O
and	O
cytoplasm	B-Organism_substance
.	O

There	O
was	O
a	O
significant	O
correlation	O
(	O
P	O
=	O
0	O
.	O
022	O
)	O
between	O
survivin	O
and	O
bcl	O
-	O
x	O
expression	O
;	O
survivin	O
and	O
bcl	O
-	O
x	O
tended	O
to	O
correlate	O
with	O
overall	O
survival	O
(	O
P	O
=	O
0	O
.	O
072	O
and	O
0	O
.	O
075	O
,	O
respectively	O
)	O
,	O
but	O
not	O
with	O
disease	O
-	O
free	O
survival	O
(	O
P	O
=	O
0	O
.	O
19	O
and	O
0	O
.	O
18	O
,	O
respectively	O
)	O
.	O

There	O
was	O
no	O
correlation	O
of	O
survivin	O
with	O
bcl	O
-	O
2	O
or	O
bax	O
expression	O
,	O
or	O
with	O
other	O
prognostic	O
parameters	O
(	O
age	O
,	O
tumor	B-Cancer
size	O
,	O
histologic	O
type	O
,	O
histologic	O
grade	O
,	O
nodal	B-Multi-tissue_structure
status	O
,	O
and	O
tumor	B-Cancer
stage	O
)	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

CONCLUSION	O
:	O
The	O
majority	O
(	O
81	O
%	O
)	O
of	O
breast	B-Cancer
carcinomas	I-Cancer
show	O
survivin	O
expression	O
which	O
correlates	O
with	O
bcl	O
-	O
x	O
,	O
another	O
antiapoptotic	O
marker	O
,	O
and	O
both	O
markers	O
tend	O
to	O
correlate	O
with	O
prognosis	O
.	O

